anti-CD135 / FLT3 antibody [BV10A4] (PE)

ARG54230
ApplicationsFlow Cytometry
Product group Antibodies
TargetFLT3
Overview
- SupplierArigo Biolaboratories
- Product Nameanti-CD135 / FLT3 antibody [BV10A4] (PE)
- Delivery Days Customer23
- ApplicationsFlow Cytometry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDBV10A4
- ConjugateRPE
- Gene ID2322
- Target nameFLT3
- Target descriptionfms related receptor tyrosine kinase 3
- Target synonymsCD135; CD135 antigen; fetal liver kinase 2; FL cytokine receptor; FLK2; FLK-2; fms related tyrosine kinase 3; fms-like tyrosine kinase 3; growth factor receptor tyrosine kinase type III; receptor-type tyrosine-protein kinase FLT3; stem cell tyrosine kinase 1; STK1
- HostMouse
- IsotypeIgG1
- Scientific DescriptionCD135 / FLT3, also known as FLK2 or STK-1 is a receptor tyrosine kinase that plays important roles in hematopoiesis. After binding of Flt3 ligand (FL), CD135 homodimerizes and stimulates proliferation, differentiation and protects the cell from apoptosis. The loss of CD90 and gain of CD135 expression marks the loss of self-renewal in hematopoietic stem cell population. Detectable CD135 expression appears first at low levels on the surface of primitive multilineage progenitor cells and disappears during defined stages of B-cell development, but is upregulated and maintained during maturation of monocytes. CD135 is also expressed on thymocytes, dendritic cell progenitors and on mature dendritic cells, as well as on various malignant hematopoietic cells.
- Storage Instruction2°C to 8°C
- UNSPSC12352203